secwatch / observer
8-K filed May 29, 2026, 9:56 AM ET ticker REPL CIK 0001737953
regulatory confidence high sentiment positive materiality 0.80

Replimune to resubmit RP1 BLA for advanced melanoma; FDA agrees to prioritize review

Replimune Group, Inc.

item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001104659-26-068002
form_type
8-K
ticker
REPL
cik
0001737953
company_name
Replimune Group, Inc.
filed_at
2026-05-29T13:56:10+00:00
discovered_at
2026-05-29T13:57:00.201243+00:00
generated_at
2026-05-29T13:57:13.665470+00:00
sec_items
["7.01", "9.01"]
event_type
regulatory
sentiment
positive
materiality_score
0.8
calibrated_materiality_score
0.8
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001104659-26-068002
json_url
https://secwatch.observer/filing/0001104659-26-068002.json
markdown_url
https://secwatch.observer/filing/0001104659-26-068002.md
text_url
https://secwatch.observer/filing/0001104659-26-068002.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1737953/000110465926068002/0001104659-26-068002-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1737953/000110465926068002/tm2615980d1_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Comparable filings

NJR

NJNG files base rate case seeking $157.6M increase; offers 8.9% winter bill cut

NEW JERSEY RESOURCES CORP June 1, 2026, 4:03 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CDT

CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan

CDT Equity Inc. May 28, 2026, 4:30 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

BCDA

BioCardia Japan PMDA supports CardiAMP cell therapy submission for HFrEF; submission planned Q4 2026

BioCardia, Inc. May 28, 2026, 8:00 AM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

CHAR

Charlton Aria receives Nasdaq delinquency notice for untimely Q1 10-Q filing

Charlton Aria Acquisition Corp May 27, 2026, 4:41 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

JAGX

Jaguar Health regains Nasdaq Bid Price compliance; monitoring until May 2027

Jaguar Health, Inc. May 27, 2026, 9:10 AM ET regulatory Items 7.01, 8.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

VSTD

Vestand receives Nasdaq delisting notice for late quarterly and annual filings

Vestand Inc. May 26, 2026, 5:18 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

PODD

Insulet voluntary correction for ~7M Omnipod Pods due to cannula tear, up to $50M cost

INSULET CORP May 26, 2026, 4:06 PM ET regulatory Items 7.01, 9.01

same SEC item: 7.01, 9.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0001104659-26-068002
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.